| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |